Low Hemoglobin Linked to 66% Higher Dementia Risk in 9-Year Study
A Swedish study of 2,300 older adults found anemia raises dementia risk 66%, spiking to 3.6x when paired with Alzheimer's biomarkers.
802 articles
A Swedish study of 2,300 older adults found anemia raises dementia risk 66%, spiking to 3.6x when paired with Alzheimer's biomarkers.
Daraxonrasib extended median survival to 13.2 months vs 6.7 months on chemo in a Phase 3 trial โ a potential landmark for one of cancer's deadliest diagnoses.
Rockefeller scientists reprogrammed blood stem cells to produce rare broadly neutralizing antibodies, offering a potential one-time immunity platform.
A new wave of biotechs is targeting aging as a root cause, using encapsulated cells and gene therapy to restore lost proteins and reverse decline.
Seragon's oral combo therapy SRN-901 outperforms rapamycin in mice, boosting lifespan and slashing frailty through multi-pathway aging intervention.
UCLA researchers eliminated senescent immune cells in mice, dramatically reversing liver damage even without diet changes.
New research reveals how hormone FGF21 activates brain circuits to boost metabolism and reverse obesity, offering alternative to GLP-1 drugs.
New research shows purple potatoes cause smaller insulin spikes and reduce inflammation markers compared to white and yellow varieties.
New comprehensive review questions effectiveness of amyloid-targeting Alzheimer's drugs, igniting debate over treatment approach.
New study suggests Lilly's tirzepatide leads to more lean muscle loss compared to Novo's semaglutide, despite superior weight loss results.
New system provides real-time access to safety reports for drugs, vaccines, supplements, and medical devices in one searchable platform.
New 7.2mg Wegovy HD approved in just 54 days, offering greater weight reduction potential for obesity treatment.